Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05721287
Status:
RECRUITING
Last Update Posted:
2023-02-10
First Post:
2023-01-31
Brief Title:
A Phase 1 Randomized Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults
Sponsor:
Sparian Biosciences Inc
Organization:
Sparian Biosciences Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-31
First Submit QC Date:
January 31 2023
Study First Post Date:
2023-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-31
Last Update Post Date:
2023-02-10
Last Update Post Date Type:
ACTUAL